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Background: Protein kinases are involved in relevant physiological functions and a broad number of mutations in
this superfamily have been reported in the literature to affect protein function and stability. Unfortunately, the
exploration of the consequences on the phenotypes of each individual mutation remains a considerable challenge.
Results: The wKinMut web-server offers direct prediction of the potential pathogenicity of the mutations from a
number of methods, including our recently developed prediction method based on the combination of information
from a range of diverse sources, including physicochemical properties and functional annotations from FireDB and
Swissprot and kinase-specific characteristics such as the membership to specific kinase groups, the annotation with
disease-associated GO terms or the occurrence of the mutation in PFAM domains, and the relevance of the residues
in determining kinase subfamily specificity from S3Det. This predictor yields interesting results that compare
favourably with other methods in the field when applied to protein kinases.
Together with the predictions, wKinMut offers a number of integrated services for the analysis of mutations. These
include: the classification of the kinase, information about associations of the kinase with other proteins extracted
from iHop, the mapping of the mutations onto PDB structures, pathogenicity records from a number of databases
and the classification of mutations in large-scale cancer studies. Importantly, wKinMut is connected with the SNP2L
system that extracts mentions of mutations directly from the literature, and therefore increases the possibilities of
finding interesting functional information associated to the studied mutations.
Conclusions: wKinMut facilitates the exploration of the information available about individual mutations by
integrating prediction approaches with the automatic extraction of information from the literature (text mining)
and several state-of-the-art databases.
wKinMut has been used during the last year for the analysis of the consequences of mutations in the context of a
number of cancer genome projects, including the recent analysis of Chronic Lymphocytic Leukemia cases and is
publicly available at http://wkinmut.bioinfo.cnio.es.Background
Current high-throughput resequencing screenings [1-3]
represent a powerful set of techniques to discover large
numbers of mutations. Of these, only a small fraction
are causally implicated in disease onset and therefore,
separating the wheat from the chaff is still a major chal-
lenge [4]. The interpretation of the overwhelming wealth* Correspondence: josemgizarzugaza@cbs.dtu.dk; avalencia@cnio.es
1Structural Biology and BioComputing Programme, Spanish National Cancer
Research Centre (CNIO), C/Melchor Fernandez Almagro, 3, E-28029 Madrid,
Spain
2Department of Systems Biology, Center for Biological Sequence Analysis,
Technical University of Denmark, 2800 Lyngby, Denmark
© 2013 Izarzugaza et al.; licensee BioMed Cen
Commons Attribution License (http://creativec
reproduction in any medium, provided the orof data also represents an issue in other fields, such as
protein function prediction [5]. For a small subset of the
new mutations discovered, experimental information re-
garding the relationship between the mutation and the
underlying biochemical mechanism is known. However,
there is no information for the remaining mutations.
The intensive requirement of resources makes it unfeas-
ible to experimentally test the association of all these
mutations to disease, and to characterize their functional
effects. Nevertheless, this problem is very amenable to in
silico predictors [4,6,7]. Different approaches are cur-
rently available to predict the probability of a newlytral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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methods identify crucial positions in a given protein and
derive generalized rules to predict the pathogenicity of
mutations. Other methods assume that evolutionarily
conserved protein residues are important for protein
structure, folding and function, whereby mutations in
these residues are considered deleterious [8]. Variations
on this principle lead to methods that predict deleterious
mutations by evaluating changes in evolutionarily
conserved PFAM motifs [9]. A number of systems use
protein structures to characterize substitutions that
significantly destabilize the folded state. There are also
methods that integrate prior knowledge in the form of
both sequence and structure-related features from a
set of experimentally characterized mutations to train
automatic machine-learning systems. These systems
can infer the pathogenicity of new mutations based on
the cases evaluated. Albeit similar in purpose, very dif-
ferent machine-learning methods can be implemented.
Among them, probably the most popular ones are:
rule-based systems [10-12], decision trees [13], random
forests [14,15], neural networks [16,17], Bayesian
methods [18] and SVMs [19-23]. Recently, some meta
approaches that combine different methodologies have
been implemented. For example, Condel [24] inte-
grates five of the most widely employed computational
tools for detecting pathogenic single nucleotide varia-
tions. Predictors can also be classified according to
their scope. Most of the predictors are generally
applicable to amino acid sequences from any protein
family, while a few of them include properties that
apply only to a given protein family of interest; i.e. pro-
tein kinase specific predictors [20,23]. These family-
related features bring discriminative information that
justifies the development of specialized predictors.
A broad number of mutations in the protein kinase
superfamily have been reported in the literature [25] and
a subset of them is known to disrupt protein structure
and function [26]. For some cases, since human protein
kinases are involved in a plethora of physiological func-
tions, this disruption can be causally associated to dis-
ease [27]. Still, the majority of protein kinase mutations
are tolerated without apparent significant effects [28,29].
In previous publications, we have discussed the prefer-
ential distribution of germline pathogenic deviations [30]
and driver somatic mutations [31] with respect to re-
gions of functional and structural importance. Here we
present, wKinMut, an integrated web-service for the
collection of information from multiple sources and for
the prediction of the pathogenicity of mutations by com-
bining several prediction approaches. The objective of
wKinMut is to provide a one-stop resource for the
analysis and interpretation of the consequences of
mutations in the protein kinase superfamily.Implementation
wKinMut represents the first resource to provide an in-
tegrated tool for the analysis and interpretation of the
consequences of mutations in the protein kinase
superfamily. The main objective of wKinMut is to
aid computational biologists and clinicians to prioritize
pathogenic mutations and to understand the mecha-
nisms by which some mutations lead to disease, and
particularly, to cancer.
The tool presented here, incorporates information
retrieval and prediction approaches and displays infor-
mation from diverse sources. First, it simplifies the
collection of information about the mutations, such as
the classification, domain architecture, functional anno-
tations and plausible interaction partners of the kinase.
Furthermore, kinase mutations are analyzed in their
structural context and mentions in dedicated databases,
genotyping studies and the literature that suggest an im-
plication in disease are also presented. Second, wKinMut
estimates the theoretical pathogenicity of kinase muta-
tions with three different approaches, including our
newly developed kinase-specific method, KinMut [23],
based on the evaluation of a wide set of sequence-
derived features that describe each independent muta-
tion. The affected domain and kinase group, diverse
functional annotations, residue physicochemical proper-
ties and relevance of the mutated residues in determin-
ing subfamily specificity are considered.
wKinMut has been implemented mostly in Ruby. The
functionality is implemented as a workflow accessible
through a REST interface that can render the results
either in JSON format or HTML. The later constitutes
the interface described in this document. Some of
data resources that support this system, such as gene
descriptions or iHOP interactions, are queried remotely
through the internet as demanded; but are then cached
to improve subsequent accesses. The server incorporates
some additional caching schemes to improve perform-
ance in the back-end, by persisting the job results, and
in the web interface, by caching the HTML.
Web interface
Step 1: submission of mutations for analysis
The input to wKinMut are non-synonymous mutations
in the protein kinase superfamily. The input format
should encode the Uniprot/Swissprot accession number,
the wild type residue, the position and the mutated resi-
due. Non-standard amino acids and truncating muta-
tions will be excluded from the analysis. An example of
this format would be a mutation from Glycine to
Alanine in position 719 of the human epidermal growth
factor receptor, which is encoded as P00533 G719A. In
the following sections, we will use this example to guide
the reader through the different result views (Figure 1).
Figure 1 Summary of the different result pages in wKinMut: Example of a Gly-719-Ala mutation in the human epidermal growth factor
receptor. The figure shows an example of an input to the server (panel a) and the results summary table (panel b). The rest of panels display
show the different outputs from the server, including the gene/protein summary tab (panel c), the domain tab (panel d), the structure view
(panel e), the pathogenicity assessment (panel f). Information from the databases, the literature and iHop is exemplified in panels g, h and
i respectively.
Izarzugaza et al. BMC Bioinformatics 2013, 14:345 Page 3 of 7
http://www.biomedcentral.com/1471-2105/14/345Multiple mutations can be submitted at a time, either
as a plain text file or directly via the applications form,
the sample dataset provided as part of wKinMut’s
documentation can be used as a formatting guide.Step 2: interpretation of the consequences of the mutations
The first output the user will get right after submitting
the mutations is a summary page with useful informa-
tion about the requested mutations (Figure 1, panel b).
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membership to kinase groups in the classification in
KinBase [32,33] and the estimation of the pathogenicity
of mutations attending to our kinase-specific predictor
of pathogenicity, KinMut [23]. The prediction of the
pathogenicity will be discussed in detail in a forthcoming
section, nevertheless we decided to include this informa-
tion at this step as a guide to prioritize mutations. It
might be interesting to point out here that users inter-
ested only in the results from KinMut, can find a link to
the predictions in this summary page that can be
accessed programmatically. The scope of wKinMut goes
beyond providing raw prediction of pathogenicity from
KinMut, the web-service’s main goal is to aid computa-
tional biologists and clinicians to understand and to in-
terpret the consequences of kinase mutations. Hence,
information complementary to KinMut predictions, is
provided. In the summary table, the ‘View’ link in the
right-most ‘Details’ column (Figure 1, panel b) will redir-
ect the user to another page containing this complemen-
tary information, which includes: the values of the
features used for classification, PFAM domains affected
by the mutation, protein-protein interaction information
extracted from the literature with iHop [34], mentions
of the mutations in the literature automatically mined
with SNP2L [25,35], and existing records of the muta-
tions in other dedicated databases. This additional infor-
mation is intended to provide the basic background to
help to understand and interpret the consequences of
the mutations. Each individual piece of information will
be discussed thoroughly in the following sections.
General information about the protein/gene Informa-
tion under the ‘gene/protein’ tab (Figure 1, panel c) fo-
cuses on information shared by all mutations in the
same kinase. Background information such as the gene
name, the formal description in Uniprot and the classifi-
cation in KinBase [32,33] of the kinase is provided. In
addition, the system provides the Gene Ontology terms
with which the kinase has been annotated in each of the in-
dependent sub-ontologies (namely Molecular Function,
Cellular Compartment and Biological Process). This infor-
mation provides clues to unveil the function of the kinase
and it is used by KinMut to calculate the likeness of the
protein (and subsequently the mutation) to play a role in
disease.
PFAM domains In a previous publication [23] we dem-
onstrated that mutations occurring in certain domains
such as the Tyrosine kinase domain (PKinase Tyr, ac-
cording to PFAM) are more likely to cause disease. This
is coherent with the assumption that the function of
some domains is more important than the function of
others. In wKinMut, this information is contained in the‘PFAM domains’ tab (Figure 1, panel d), which displays
the domain (or domains, in some cases) where the
mutation is occurring and the alignment used by PFAM
as seed to generate the domain family. The alignment is
evaluated in terms of sequence conservation. Under the
assumption that conserved regions have been preserved
by evolution, this information can help the user to iden-
tify important regions in the structure of the domain.
Mapping the mutations onto structures To under-
stand the consequences of mutations might have in
protein stability and function it is sometimes useful to
study the mutations in their structural contexts. How-
ever, mapping mutations from sequences to structures is
not always trivial [36]. Under the ‘Structures‘ tab, wKinMut
enables the visualization of the mutation mapped to all
available structures. (Figure 1, panel e). In addition, the ver-
satility of the Jmol applet implemented in wKinMut allows
advanced users to adapt the visualization to their specific
needs.
Prediction of the pathogenicity In wKinMut the theor-
etical pathogenicity of mutations is assessed by two in-
dependent methods, namely SIFT [8] and KinMut [23].
This information is displayed in the ‘Pathogenicity’ tab
(Figure 1, panel f ). SIFT [8] predicts whether non-
synonymous mutations are prone to affect protein func-
tion. This prediction is based on the degree of conserva-
tion of the residues in sequence alignments derived from
closely related sequences. A threshold value of 0.05 is used
to determine that mutations are likely to be pathogenic.
KinMut [23] is a kinase-specific predictor of the pathogen-
icity of mutations. It relies in a machine-learning approach
(SVM) to evaluate a number of sequence-derived features
that describe kinase mutations from different perspec-
tives, including: a) at the gene level, the membership to
a Kinbase group and Gene Ontology terms. b) at the
domain level, the occurrence of the mutation inside a
PFAM domain, and c) at the residue level, several
properties including amino acid type, functional anno-
tations from Swissprot and FireDB [37], specificity-
determining positions, etc. SVM scores greater than -0.5
indicate that the mutation is very likely pathogenic. The
values of these features are also displayed in this section of
the web-service to aid to interpret the predictions. Please,
refer to the original publications for information on the in-
dividual characteristics, capabilities and validation of each
predictor.
Mutations in databases The wealth of knowledge pro-
vided by current research is usually stored in databases. A
number of them store information about mutations from
diverse perspectives. In wKinMut (Figure 1, panel g) we
collect information from four different sources (namely the
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and COSMIC [40]) in an attempt to cover all aspects of
protein kinase mutation. The information displayed in-
cludes information about the structural consequences of
mutations, experiments associating mutations with a cer-
tain disease, or the proof that a mutation has been observed
in a cancer sample.
Automatic extraction of mutations from the litera-
ture Unfortunately, the databases referred in the previ-
ous section do not contain all current knowledge about
mutations. Even in the cases where a database record
exists, the knowledgebase cannot always store all con-
textual information. The context is sometimes very im-
portant for the correct interpretation of the predictions:
experimental conditions, patients’ habits and clinical his-
tories, etcetera. wKinMut provides pointers to mentions
of the mutations in the literature under the ‘Literature’
tab (Figure 1, panel h). We extract this information
automatically using our in-house text mining approach,
SNP2L [25]. In brief, SNP2L is a literature mining pipe-
line for the automatic extraction and disambiguation of
singlepoint mutation mentions from both abstracts as
well as full text articles, followed by a sequence valid-
ation check to link mutations to their corresponding
kinase protein sequences.
Automatic determination of interaction partners
wKinMut integrates Protein-Protein Interactions (PPI)
gathered from iHOP in the homonymous tab (Figure 1,
panel i). Briefly, iHOP is a powerful text mining system
to automatically extract protein protein interactions
from PubMed abstracts. To relate the interaction infor-
mation with its context, the sentences including the
interaction mentions are also provided.
Conclusion
wKinMut facilitates the exploration of the information
available about individual mutations by integrating pre-
diction approaches with the automatic extraction of in-
formation from the literature (text mining) and several
currently available databases. wKinMut works as an
open accessible web server.
The system offers direct prediction of the potential
pathogenicity of the mutations from a number of
methods, including our recently developed prediction
method based on the combination of information from
a range of diverse sources with a machine learning sys-
tem [23]. The features used by our new prediction
system include: general physicochemical properties,
annotations of known functional sites from FireDB and
Swissprot and kinase-specific characteristics such as
membership to a specific group of kinases, annotations
of disease associations extracted from GO terms andmapping of PFAM domains, and relevance of the resi-
dues for the differences between groups of kinases. In
addition to the predictions, wKinMut offers a number
of integrated complementary services that help to
understand the consequences and the mechanism of
the mutations. These services include the classification
of the kinase, information about associations of the
kinase with other proteins extracted directly extracted
from the Medline abstracts, the mutations on the
corresponding protein structures, and possible rela-
tions with pathogenicity recorded in disease-variation
databases and from large-scale cancer studies. An im-
portant component of wKinMut is the access to infor-
mation about the mutations extracted directly from
the literature. This information is important for the
contextualization of the consequences of the muta-
tions. wKinMut uses our previously developed SNP2L
[25], that has been shown to provide a substantial
addition to the information provided by public data-
bases and repositories.
In summary, we think that wKinMut constitutes a
powerful one-stop shop for the study of the potential
pathogenic potential of mutations in protein kinases. As
such, wKinMut will be of interest for bioinformaticians
and computational biologists that can use the informa-
tion provided by the server programmatically as part of
their own analysis pipelines, and it can be also useful to
biologists and clinicians who can browse and explore
punctual information easily from the provided interface.
We have used wKinMut during the past year for the
analysis of the consequences of mutations in the context
of a number of personalized cancer genome projects
(see [41]), including the recent analysis of Chronic
Lymphocytic Leukemia cases [42,43].
A further development of the presented system would
consider the analysis of the downstream consequences
of mutations in relation to potential and known post-
translational modifications and their interelations (see
[44,45]). We are interested in extending wKinMut cap-
abilities to the analysis of the combined effect of muta-
tions in pathways and signalling networks in where
kinases are essential components wKinMut is publicly
available at http://wkinmut.bioinfo.cnio.es.
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